RxDoctor Payments Data

Ramiro Icaza, MD

Family Medicine · Sikeston, MONPI 1457463960

Payments from drug & device makers

$2,506in general payments, 2019–2025

Across 87 payments — averaging $28.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$434
  • AbbVie$404
  • Lilly USA, LLC$281
  • Amgen$241
  • AstraZeneca$210
  • Biowound Solutions, Inc.$143
  • plus $793 from 23 others

What the payments were for

  • Food & beverage$2,506100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,506 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$7,863
Medicare patients
54
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,746
MounjaroTirzepatide14$12,147
JanuviaSitagliptin Phosphate12$7,413
Ventolin HfaAlbuterol Sulfate26$1,584
Albuterol Sulfate HfaAlbuterol Sulfate18$533
Metoprolol Succinate39$514
Gabapentin25$499
Tamsulosin Hcl20$485
Rosuvastatin Calcium23$467
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$398
Triamcinolone Acetonide22$356
Duloxetine Hcl20$303
Amitriptyline Hcl11$249
Metformin Hcl39$237
Pantoprazole Sodium38$207

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere$210$15,74624 claims
Lilly USA, LLCMounjaro$281$12,14714 claims
MerckJanuvia$12$7,41312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Sikeston

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →